664 related articles for article (PubMed ID: 19260819)
1. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
[No Abstract] [Full Text] [Related]
2. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
4. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Ikematsu H; Kawai N
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
[TBL] [Abstract][Full Text] [Related]
5. Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).
National Advisory Committee on Immunization (NACI)
Can Commun Dis Rep; 2008 Jul; 34(ACS-3):1-46. PubMed ID: 18802991
[No Abstract] [Full Text] [Related]
6. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
[TBL] [Abstract][Full Text] [Related]
7. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.
Sugaya N; Mitamura K; Yamazaki M; Tamura D; Ichikawa M; Kimura K; Kawakami C; Kiso M; Ito M; Hatakeyama S; Kawaoka Y
Clin Infect Dis; 2007 Jan; 44(2):197-202. PubMed ID: 17173216
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014).
Chan-Tack KM; Kim C; Moruf A; Birnkrant DB
Antivir Ther; 2015; 20(5):561-4. PubMed ID: 25667992
[TBL] [Abstract][Full Text] [Related]
9. Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.
Zaraket H; Saito R; Wakim R; Tabet C; Medlej F; Reda M; Baranovich T; Suzuki Y; Dapat C; Caperig-Dapat I; Dbaibo GS; Suzuki H
J Med Virol; 2010 Jul; 82(7):1224-8. PubMed ID: 20513088
[TBL] [Abstract][Full Text] [Related]
10. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
Ferraris O; Kessler N; Lina B
Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
[TBL] [Abstract][Full Text] [Related]
12. Update: influenza activity - United States, September 28, 2008--January 31, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(5):115-9. PubMed ID: 19214161
[TBL] [Abstract][Full Text] [Related]
13. Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
Saito R; Sato I; Suzuki Y; Baranovich T; Matsuda R; Ishitani N; Dapat C; Dapat IC; Zaraket H; Oguma T; Suzuki H
Pediatr Infect Dis J; 2010 Oct; 29(10):898-904. PubMed ID: 20442686
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.
Wkly Epidemiol Rec; 2007 Apr; 82(17):149-50. PubMed ID: 17465078
[No Abstract] [Full Text] [Related]
15. Global transmission of oseltamivir-resistant influenza.
Moscona A
N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
[No Abstract] [Full Text] [Related]
16. FDA notifications. EUA issued for treating novel 2009 H1N1 flu.
AIDS Alert; 2009 Jun; 24(6):69-70. PubMed ID: 19544608
[No Abstract] [Full Text] [Related]
17. Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus.
Medeiros R; Rameix-Welti MA; Lorin V; Ribaud P; Manuguerra JC; Socie G; Scieux C; Naffakh N; van der Werf S
Antivir Ther; 2007; 12(4):571-6. PubMed ID: 17668567
[TBL] [Abstract][Full Text] [Related]
18. The course of fever following influenza virus infection in children treated with oseltamivir.
Suzuki E; Ichihara K
J Med Virol; 2008 Jun; 80(6):1065-71. PubMed ID: 18428131
[TBL] [Abstract][Full Text] [Related]
19. Swine flu outbreak. What role for antiviral drugs?
Couzin-Frankel J
Science; 2009 May; 324(5928):705. PubMed ID: 19423784
[No Abstract] [Full Text] [Related]
20. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]